Daanish Jamal is the Founder and CEO of Dolomite Therapeutics, a biotechnology company developing novel therapeutics. Before Dolomite, Jamal was a principal and entrepreneur-in-residence at the life-sciences fund SR One, worked in business development at Skyhawk and Dragonfly Therapeutics, and was an associate partner at GreatPoint Ventures. He holds a BSBA in finance from Georgetown University.